1	Non-O1	Non-O1	B-NP	JJ	O	4	NMOD
2	Vibrio	Vibrio	I-NP	NNP	O	4	NMOD
3	cholerae	cholerae	I-NP	NN	O	4	NMOD
4	bacteremia	bacteremia	I-NP	NN	O	11	NMOD
5	in	in	B-PP	IN	O	4	NMOD
6	patients	patient	B-NP	NNS	O	5	PMOD
7	with	with	B-PP	IN	O	6	NMOD
8	cirrhosis	cirrhosis	B-NP	NN	O	7	PMOD
9	:	:	O	:	O	4	P
10	5-yr	5-yr	B-NP	JJ	O	11	NMOD
11	experience	experience	I-NP	NN	O	0	ROOT
12	from	from	B-PP	IN	O	11	NMOD
13	a	a	B-NP	DT	O	16	NMOD
14	single	single	I-NP	JJ	O	16	NMOD
15	medical	medical	I-NP	JJ	O	16	NMOD
16	center	center	I-NP	NN	O	12	PMOD
17	.	.	O	.	O	11	P

1	To	To	B-VP	TO	O	2	VMOD
2	assess	assess	I-VP	VB	O	18	VMOD
3	the	the	B-NP	DT	O	5	NMOD
4	clinical	clinical	I-NP	JJ	O	5	NMOD
5	features	feature	I-NP	NNS	O	7	NMOD
6	and	and	O	CC	O	7	NMOD
7	susceptibility	susceptibility	B-NP	NN	O	2	OBJ
8	of	of	B-PP	IN	O	7	NMOD
9	cirrhotic	cirrhotic	B-NP	JJ	O	10	NMOD
10	patients	patient	I-NP	NNS	O	8	PMOD
11	to	to	B-PP	TO	O	7	NMOD
12	non-O1	non-O1	B-NP	JJ	O	15	NMOD
13	Vibrio	Vibrio	I-NP	NNP	O	15	NMOD
14	cholerae	cholerae	I-NP	NN	O	15	NMOD
15	bacteremia	bacteremia	I-NP	NN	O	11	PMOD
16	and	and	O	CC	O	2	VMOD
17	to	to	B-VP	TO	O	18	VMOD
18	provide	provide	I-VP	VB	O	0	ROOT
19	our	our	B-NP	PRP$	O	21	NMOD
20	therapeutic	therapeutic	I-NP	JJ	O	21	NMOD
21	experiences	experience	I-NP	NNS	O	18	OBJ
22	in	in	B-PP	IN	O	21	NMOD
23	this	this	B-NP	DT	O	28	NMOD
24	rare	rare	I-NP	JJ	O	28	NMOD
25	and	and	I-NP	CC	O	28	NMOD
26	high	high	I-NP	JJ	O	28	NMOD
27	lethal	lethal	I-NP	JJ	O	28	NMOD
28	infection	infection	I-NP	NN	O	22	PMOD
29	.	.	O	.	O	18	P

1	Twenty-eight	Twenty-eight	B-NP	CD	O	4	NMOD
2	blood	blood	I-NP	NN	O	4	NMOD
3	culture	culture	I-NP	NN	O	4	NMOD
4	isolates	isolate	I-NP	NNS	O	9	SUB
5	of	of	B-PP	IN	O	4	NMOD
6	non-O1	non-O1	B-NP	JJ	O	8	NMOD
7	V.	V.	I-NP	NNP	O	8	NMOD
8	cholerae	cholerae	I-NP	NNS	O	5	PMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	identified	identify	I-VP	VBN	O	9	VC
11	by	by	B-PP	IN	O	10	VMOD
12	our	our	B-NP	PRP$	O	15	NMOD
13	clinical	clinical	I-NP	JJ	O	15	NMOD
14	microbiology	microbiology	I-NP	NN	O	15	NMOD
15	laboratory	laboratory	I-NP	NN	O	11	PMOD
16	between	between	B-PP	IN	O	15	NMOD
17	July	July	B-NP	NNP	O	20	NMOD
18	1989	1989	I-NP	CD	O	17	NMOD
19	and	and	O	CC	O	20	NMOD
20	June	June	B-NP	NNP	O	16	PMOD
21	1994	1994	I-NP	CD	O	20	NMOD
22	.	.	O	.	O	9	P

1	Patients	Patient	B-NP	NNS	O	9	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	underlying	underlie	B-VP	VBG	O	2	PMOD
4	cirrhosis	cirrhosis	B-NP	NN	O	8	NMOD
5	and	and	O	CC	O	8	NMOD
6	the	the	B-NP	DT	O	8	NMOD
7	aforementioned	aforementioned	I-NP	JJ	O	8	NMOD
8	bacteremia	bacteremia	I-NP	NN	O	3	OBJ
9	were	be	B-VP	VBD	O	0	ROOT
10	retrospectively	retrospectively	I-VP	RB	O	9	VMOD
11	reviewed	review	I-VP	VBN	O	9	VC
12	.	.	O	.	O	9	P

1	Twenty-one	Twenty-one	B-NP	CD	O	3	NMOD
2	cirrhotic	cirrhotic	I-NP	JJ	O	3	NMOD
3	patients	patient	I-NP	NNS	O	21	SUB
4	(	(	O	(	O	20	DEP
5	16	16	B-NP	CD	O	9	NMOD
6	male	male	I-NP	JJ	O	5	NMOD
7	,	,	O	,	O	9	P
8	five	five	B-NP	CD	O	9	NMOD
9	female	female	I-NP	JJ	O	12	NMOD
10	;	;	O	:	O	9	P
11	mean	mean	B-NP	NN	O	12	NMOD
12	age	age	I-NP	NN	O	15	NMOD
13	,	,	O	,	O	15	P
14	50.9	50.9	B-NP	CD	O	15	NMOD
15	yr	yr	I-NP	NN	O	19	NMOD
16	;	;	O	:	O	19	P
17	range	range	B-NP	NN	O	19	NMOD
18	28-67	28-67	I-NP	CD	O	19	NMOD
19	yr	yr	I-NP	NN	O	20	DEP
20	)	)	O	)	O	3	NMOD
21	were	be	B-VP	VBD	O	0	ROOT
22	identified	identify	I-VP	VBN	O	21	VC
23	and	and	O	CC	O	22	VMOD
24	classified	classify	B-VP	VBN	O	22	VMOD
25	as	as	B-PP	IN	O	24	VMOD
26	Child	Child	B-NP	NN	O	27	NMOD
27	B	B	I-NP	NN	O	34	NMOD
28	(	(	O	(	O	31	DEP
29	6	6	B-NP	CD	O	30	NMOD
30	cases	case	I-NP	NNS	O	31	DEP
31	)	)	O	)	O	27	NMOD
32	and	and	O	CC	O	34	NMOD
33	Child	Child	B-NP	NN	B-protein	34	NMOD
34	C	C	I-NP	NN	I-protein	25	PMOD
35	(	(	O	(	O	38	DEP
36	15	15	B-NP	CD	O	37	NMOD
37	cases	case	I-NP	NNS	O	38	DEP
38	)	)	O	)	O	34	NMOD
39	.	.	O	.	O	21	P

1	Bacteremic	Bacteremic	B-NP	JJ	O	2	NMOD
2	episodes	episode	I-NP	NNS	O	3	SUB
3	occurred	occur	B-VP	VBD	O	0	ROOT
4	most	most	B-ADVP	RBS	O	5	AMOD
5	often	often	I-ADVP	RB	O	3	VMOD
6	from	from	B-PP	IN	O	5	AMOD
7	March	March	B-NP	NNP	O	6	PMOD
8	to	to	B-PP	TO	O	5	AMOD
9	September	September	B-NP	NNP	O	8	PMOD
10	.	.	O	.	O	3	P

1	Seafood	Seafood	B-NP	NN	O	2	NMOD
2	ingestion	ingestion	I-NP	NN	O	9	NMOD
3	(	(	O	(	O	6	DEP
4	seven	seven	B-NP	CD	O	5	NMOD
5	cases	case	I-NP	NNS	O	6	DEP
6	)	)	O	)	O	2	NMOD
7	and	and	O	CC	O	9	NMOD
8	seawater	seawater	B-NP	NN	O	9	NMOD
9	exposure	exposure	I-NP	NN	O	14	SUB
10	(	(	O	(	O	13	DEP
11	two	two	B-NP	CD	O	12	NMOD
12	cases	case	I-NP	NNS	O	13	DEP
13	)	)	O	)	O	9	NMOD
14	were	be	B-VP	VBD	O	21	VMOD
15	risk	risk	B-NP	NN	O	16	NMOD
16	factors	factor	I-NP	NNS	O	14	PRD
17	,	,	O	,	O	21	P
18	but	but	O	CC	O	21	VMOD
19	nosocomial	nosocomial	B-NP	JJ	O	20	NMOD
20	infections	infection	I-NP	NNS	O	21	SUB
21	were	be	B-VP	VBD	O	0	ROOT
22	also	also	I-VP	RB	O	21	VMOD
23	noted	note	I-VP	VBN	O	21	VC
24	in	in	B-PP	IN	O	23	VMOD
25	six	six	B-NP	CD	O	26	NMOD
26	cases	case	I-NP	NNS	O	24	PMOD
27	.	.	O	.	O	21	P

1	Presenting	Present	B-VP	VBG	O	4	NMOD
2	symptoms	symptom	B-NP	NNS	O	4	NMOD
3	and	and	I-NP	CC	O	4	NMOD
4	signs	sign	I-NP	NNS	O	5	SUB
5	included	include	B-VP	VBD	O	0	ROOT
6	ascites	ascite	B-NP	NNS	O	32	NMOD
7	(	(	O	(	O	10	DEP
8	95.2	95.2	B-NP	CD	O	9	NMOD
9	%	%	I-NP	NN	O	10	DEP
10	)	)	O	)	O	6	NMOD
11	,	,	O	,	O	32	P
12	fever	fever	B-NP	NN	O	32	NMOD
13	(	(	O	(	O	16	DEP
14	81	81	B-NP	CD	O	15	NMOD
15	%	%	I-NP	NN	O	16	DEP
16	)	)	O	)	O	12	NMOD
17	,	,	O	,	O	32	P
18	abdominal	abdominal	B-NP	JJ	O	19	NMOD
19	pain	pain	I-NP	NN	O	32	NMOD
20	(	(	O	(	O	23	DEP
21	52.4	52.4	B-NP	CD	O	22	NMOD
22	%	%	I-NP	NN	O	23	DEP
23	)	)	O	)	O	19	NMOD
24	,	,	O	,	O	32	P
25	diarrhea	diarrhea	B-NP	NN	O	32	NMOD
26	(	(	O	(	O	29	DEP
27	33.3	33.3	B-NP	CD	O	28	NMOD
28	%	%	I-NP	NN	O	29	DEP
29	)	)	O	)	O	25	NMOD
30	,	,	O	,	O	32	P
31	and	and	O	CC	O	32	NMOD
32	cellulitis	cellulitis	B-NP	NN	O	5	OBJ
33	with	with	B-PP	IN	O	32	NMOD
34	bullae	bullae	B-NP	NN	O	35	NMOD
35	formation	formation	I-NP	NN	O	33	PMOD
36	(	(	O	(	O	39	DEP
37	19	19	B-NP	CD	O	38	NMOD
38	%	%	I-NP	NN	O	39	DEP
39	)	)	O	)	O	35	NMOD
40	.	.	O	.	O	5	P

1	Concurrent	Concurrent	B-NP	JJ	O	4	NMOD
2	spontaneous	spontaneous	I-NP	JJ	O	4	NMOD
3	bacterial	bacterial	I-NP	JJ	O	4	NMOD
4	peritonitis	peritonitis	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	0	ROOT
6	determined	determine	I-VP	VBN	O	5	VC
7	in	in	B-PP	IN	O	6	VMOD
8	10	10	B-NP	CD	O	9	NMOD
9	cases	case	I-NP	NNS	O	7	PMOD
10	,	,	O	,	O	11	P
11	seven	seven	B-NP	CD	O	5	VMOD
12	with	with	B-PP	IN	O	11	NMOD
13	positive	positive	B-NP	JJ	B-cell_line	15	NMOD
14	ascites	ascite	I-NP	NNS	I-cell_line	15	NMOD
15	cultures	culture	I-NP	NNS	I-cell_line	12	PMOD
16	.	.	O	.	O	11	P

1	Antibiotic	Antibiotic	B-NP	JJ	O	2	NMOD
2	therapy	therapy	I-NP	NN	O	0	ROOT
3	(	(	O	(	O	11	DEP
4	either	either	O	CC	O	5	NMOD
5	cephalothin	cephalothin	B-NP	NN	O	11	DEP
6	with	with	B-PP	IN	O	5	NMOD
7	gentamicin	gentamicin	B-NP	NN	O	9	NMOD
8	or	or	I-NP	CC	O	9	NMOD
9	ceftriaxone	ceftriaxone	I-NP	NN	O	6	PMOD
10	alone	alone	B-ADVP	RB	O	9	NMOD
11	)	)	O	)	O	2	NMOD
12	cured	cure	B-VP	VBN	O	2	NMOD
13	most	most	B-NP	JJS	O	12	OBJ
14	of	of	B-PP	IN	O	13	NMOD
15	the	the	B-NP	DT	O	17	NMOD
16	bacteremic	bacteremic	I-NP	JJ	O	17	NMOD
17	episodes	episode	I-NP	NNS	O	14	PMOD
18	.	.	O	.	O	2	P

1	The	The	B-NP	DT	O	4	NMOD
2	overall	overall	I-NP	JJ	O	4	NMOD
3	case-fatality	case-fatality	I-NP	NN	O	4	NMOD
4	rate	rate	I-NP	NN	O	5	SUB
5	was	be	B-VP	VBD	O	15	VMOD
6	23.8	23.8	B-NP	CD	O	7	NMOD
7	%	%	I-NP	NN	O	5	PRD
8	,	,	O	,	O	15	P
9	but	but	O	CC	O	15	VMOD
10	75	75	B-NP	CD	O	11	NMOD
11	%	%	I-NP	NN	O	15	SUB
12	of	of	B-PP	IN	O	11	NMOD
13	the	the	B-NP	DT	O	14	NMOD
14	deaths	death	I-NP	NNS	O	12	PMOD
15	were	be	B-VP	VBD	O	0	ROOT
16	observed	observe	I-VP	VBN	O	15	VC
17	in	in	B-PP	IN	O	16	VMOD
18	patients	patient	B-NP	NNS	O	17	PMOD
19	with	with	B-PP	IN	O	18	NMOD
20	skin	skin	B-NP	NN	O	21	NMOD
21	manifestation	manifestation	I-NP	NN	O	19	PMOD
22	.	.	O	.	O	15	P

1	Patients	Patient	B-NP	NNS	O	5	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	decompensated	decompensate	B-NP	VBN	O	4	NMOD
4	cirrhosis	cirrhosis	I-NP	NN	O	2	PMOD
5	are	be	B-VP	VBP	O	0	ROOT
6	susceptible	susceptible	B-ADJP	JJ	O	5	PRD
7	to	to	B-PP	TO	O	6	AMOD
8	non-O1	non-O1	B-NP	JJ	O	11	NMOD
9	V.	V.	I-NP	NNP	O	11	NMOD
10	cholerae	cholerae	I-NP	NN	O	11	NMOD
11	bacteremia	bacteremia	I-NP	NN	O	7	PMOD
12	and	and	O	CC	O	5	VMOD
13	should	should	B-VP	MD	O	5	VMOD
14	not	not	I-VP	RB	O	13	VMOD
15	ingest	ingest	I-VP	VB	O	13	VC
16	raw	raw	B-NP	JJ	O	17	NMOD
17	seafood	seafood	I-NP	NN	O	15	OBJ
18	or	or	O	CC	O	15	VMOD
19	expose	expose	B-VP	VB	O	15	VMOD
20	skin	skin	B-NP	NN	O	21	NMOD
21	wounds	wound	I-NP	NNS	O	19	OBJ
22	to	to	B-VP	TO	O	23	VMOD
23	salt	salt	I-VP	VB	O	19	VMOD
24	water	water	B-NP	NN	O	23	OBJ
25	.	.	O	.	O	5	P

1	A	A	B-NP	DT	O	3	NMOD
2	high	high	I-NP	JJ	O	3	NMOD
3	index	index	I-NP	NN	O	8	NMOD
4	of	of	B-PP	IN	O	3	NMOD
5	suspicion	suspicion	B-NP	NN	O	4	PMOD
6	and	and	O	CC	O	8	NMOD
7	early	early	B-NP	JJ	O	8	NMOD
8	administration	administration	I-NP	NN	O	11	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	antibiotics	antibiotic	B-NP	NNS	O	9	PMOD
11	may	may	B-VP	MD	O	0	ROOT
12	lower	lower	I-VP	VB	O	11	VC
13	the	the	B-NP	DT	O	15	NMOD
14	mortality	mortality	I-NP	NN	O	15	NMOD
15	rate	rate	I-NP	NN	O	12	OBJ
16	.	.	O	.	O	11	P

